Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]-Reference-Cited by-同舟云学术

Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]

Published:2011-02 Issue:2 Volume:22 Page:288-294
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Albers P.,Park S.-I.,Niegisch G.,Fechner G.,Steiner U.,Lehmann J.,Heimbach D.,Heidenreich A.,Fimmers R.,Siener R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/2/288/409340/mdq398.pdf

Reference25 articles.

1. De novo muscle invasive bladder cancer: is there a change in trend?;Vaidya;J Urol,2001

2. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer;Lehmann;BJU Int,2006

3. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

4. Randomized phase III trial of vinflunine (V) plus best supportive care (B) vs B alone as 2nd line therapy after a platinum-containing regimen in advanced transitional cell carcinoma of the urothelium (TCCU);Bellmunt;J Clin Oncol,2009

5. Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group;Roth;J Clin Oncol,1994

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Postneoadjuvant Chemotherapy Neutrophil-to-Lymphocyte Ratio in Patients undergoing Radical Cystectomy;Journal of Clinical Medicine;2024-03-28

2. Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond;Expert Opinion on Pharmacotherapy;2022-11-29

3. Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review;Translational Cancer Research;2022-07

4. Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use;Meditsinskiy sovet = Medical Council;2022-06-18

5. Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy;Cancer Management and Research;2022-06